Qualyst Transporter Solutions Revenue and Competitors
Estimated Revenue & Valuation
- Qualyst Transporter Solutions's estimated annual revenue is currently $1.1M per year.
- Qualyst Transporter Solutions's estimated revenue per employee is $155,000
Employee Data
- Qualyst Transporter Solutions has 7 Employees.
- Qualyst Transporter Solutions grew their employee count by 0% last year.
Qualyst Transporter Solutions's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Scientific Operations | Reveal Email/Phone |
Qualyst Transporter Solutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Qualyst Transporter Solutions?
Qualyst Transporter Solutions, LLC (Qualyst) provides in vitro hepatic models to predict the effect of drugs and other compounds on the human liver. Qualyst’s in vitro models integrate hepatic uptake, metabolism, regulation, and efflux and demonstrate superior in vitro-in vivo correlation compared to conventional systems. Qualyst’s proprietary technology, products, and services are used by leading pharmaceutical, nutrition, cosmetics and consumer products, and chemical companies to provide clinically-relevant answers to liver-related questions, and to address regulatory concerns about their products.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 7 | 0% | N/A |
#2 | $0.5M | 7 | -36% | N/A |
#3 | $0.5M | 7 | -12% | N/A |
#4 | $0.5M | 7 | -30% | N/A |
#5 | $0.9M | 7 | -84% | N/A |